|
Ac9-25 TFA 盐
|
A287834-1mg
|
≥95% |
284040-76-2 |
1mg
|
¥ 1999.9
|
现货 |
|
0 |
阿拉丁 |
|
12,13-二氢-5H-吲哚并[2,3-a]吡咯并[3,4-c]咔唑-5,7(6H)-二酮
|
A287816-10mg
|
≥98%(HPLC) |
118458-54-1 |
10mg
|
¥ 1029.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-[[[4-[(2.6-二甲基-3-吡啶基)氧基] -2-吡啶基]氨基]苯磺酰胺(AZ 12799734)
|
A287809-50mg
|
≥98%(HPLC) |
1117684-36-2 |
50mg
|
¥ 6179.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-[[[4-[(2.6-二甲基-3-吡啶基)氧基] -2-吡啶基]氨基]苯磺酰胺(AZ 12799734)
|
A287809-10mg
|
≥98%(HPLC) |
1117684-36-2 |
10mg
|
¥ 1853.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
AZ PFKFB3 67,PFKFB3抑制剂
|
A287807-50mg
|
≥98%(HPLC) |
1704741-11-6 |
50mg
|
¥ 6099.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
AZ PFKFB3 67,PFKFB3抑制剂
|
A287807-10mg
|
≥98%(HPLC) |
1704741-11-6 |
10mg
|
¥ 1556.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
A 804598,P2X7拮抗剂
|
A287786-50mg
|
Moligand™, ≥98% |
1125758-85-1 |
50mg
|
¥ 4048.9
|
现货 |
|
0 |
阿拉丁 |
|
A 804598,P2X7拮抗剂
|
A287786-10mg
|
Moligand™, ≥98% |
1125758-85-1 |
10mg
|
¥ 1299.9
|
现货 |
|
0 |
阿拉丁 |
|
AM 4668,FFA1(GPR40)激动剂
|
A287780-50mg
|
≥98%(HPLC) |
1011531-27-3 |
50mg
|
¥ 9178.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
AM 4668,FFA1(GPR40)激动剂
|
A287780-10mg
|
≥98%(HPLC) |
1011531-27-3 |
10mg
|
¥ 2184.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
AMT盐酸盐
|
A287779-50mg
|
≥98% |
21463-31-0 |
50mg
|
¥ 5429.9
|
现货 |
|
0 |
阿拉丁 |
|
AMT盐酸盐
|
A287779-10mg
|
≥98% |
21463-31-0 |
10mg
|
¥ 1699.9
|
现货 |
|
0 |
阿拉丁 |
|
A 196,SUV420H1 / H2抑制剂
|
A287778-50mg
|
Moligand™, ≥98%(HPLC) |
1982372-88-2 |
50mg
|
¥ 3706.9
|
现货 |
|
0 |
阿拉丁 |
|
A 196,SUV420H1 / H2抑制剂
|
A287778-10mg
|
Moligand™, ≥98%(HPLC) |
1982372-88-2 |
10mg
|
¥ 1177.9
|
现货 |
|
0 |
阿拉丁 |
|
Akt/SKG Substrate Peptide TFA
|
A287763-1mg
|
≥98% |
276680-69-4 |
1mg
|
¥ 429.9
|
现货 |
|
0 |
阿拉丁 |
|
Adaptaquin,HIF-脯氨酰羟化酶2(PHD2)抑制剂
|
A287760-50mg
|
≥97%(HPLC) |
385786-48-1 |
50mg
|
¥ 2878.9
|
现货 |
|
0 |
阿拉丁 |
|
Adaptaquin,HIF-脯氨酰羟化酶2(PHD2)抑制剂
|
A287760-10mg
|
≥97%(HPLC) |
385786-48-1 |
10mg
|
¥ 898.9
|
现货 |
|
0 |
阿拉丁 |
|
3-AQC,5-HT3拮抗剂
|
A287758-50mg
|
≥98% |
201216-42-4 |
50mg
|
¥ 1945.9
|
现货 |
|
0 |
阿拉丁 |
|
3-AQC,5-HT3拮抗剂
|
A287758-10mg
|
≥98% |
201216-42-4 |
10mg
|
¥ 647.9
|
现货 |
|
0 |
阿拉丁 |
|
3-[(4-氯苯基)甲氧基]-N-[(1S)-1-苯基乙基]-2-噻吩甲酰胺
|
A287712-5mg
|
Moligand™, ≥98% |
1203680-76-5 |
5mg
|
¥ 648.9
|
现货 |
|
0 |
阿拉丁 |
|
3-[(4-氯苯基)甲氧基]-N-[(1S)-1-苯基乙基]-2-噻吩甲酰胺
|
A287712-25mg
|
Moligand™, ≥98% |
1203680-76-5 |
25mg
|
¥ 2001.9
|
现货 |
|
0 |
阿拉丁 |
|
ABT 639,CaV3.2和CaV3.1通道阻滞剂
|
A287699-10mg
|
Moligand™, ≥98%(HPLC) |
1235560-28-7 |
10mg
|
¥ 1501.9
|
现货 |
|
0 |
阿拉丁 |
|
A 1070722,GSK-3抑制剂
|
A287682-50mg
|
≥98% |
1384424-80-9 |
50mg
|
¥ 2360.9
|
现货 |
|
0 |
阿拉丁 |
|
A 1070722,GSK-3抑制剂
|
A287682-10mg
|
≥98% |
1384424-80-9 |
10mg
|
¥ 628.9
|
现货 |
|
0 |
阿拉丁 |